The present study evaluated and attempted to correlate the variation in choroidal thickness with the improvement in macular edema in response to intravitreal therapy with anti-VEGF (aflibercept) or corticosteroids (dexamethasone) in type 2 diabetic patients. Here, VEGFA is linked to macular retinal edema.